Identification of anticancer OATP2B1 substrates by an in vitro triple-fluorescence-based cytotoxicity screen

Tímea Windt, Szilárd Tóth, Izabel Patik, Judit Sessler, Nóra Kucsma, Áron Szepesi, Barbara Zdrazil, C. Özvegy-Laczka, G. Szakács

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Membrane transporters play an important role in the absorption, distribution, metabolism and excretion of drugs. The cellular accumulation of many drugs is the result of the net function of efflux and influx transporters. Efflux transporters such as P-glycoprotein/ABCB1 have been shown to confer multidrug resistance in cancer. Although expression of uptake transporters has been confirmed in cancer cells, their role in chemotherapy response has not been systematically investigated. In the present study we have adapted a fluorescence-based cytotoxic assay to characterize the influence of key drug-transporters on the toxicity of approved anticancer drugs. Co-cultures of fluorescently labeled parental and transporter-expressing cells (expressing ABCB1, ABCG2 or OATP2B1) were screened against 101 FDA-approved anticancer drugs, using a novel, automated, triple fluorescence-based cytotoxicity assay. By measuring the survival of parental and transporter-expressing cells in co-cultures, we identify those FDA-approved anticancer drugs, whose toxicity is influenced by ABCB1, ABCG2 or OATP2B1. In addition to confirming known substrates of ABCB1 and ABCG2, the fluorescence-based cytotoxicity assays identified anticancer agents whose toxicity was increased in OATP2B1 expressing cells. Interaction of these compounds with OATP2B1 was verified in dedicated transport assays using cell-impermeant fluorescent substrates. Understanding drug-transporter interactions is needed to increase the efficacy of chemotherapeutic agents. Our results highlight the potential of the fluorescence-based HT screening system for identifying transporter substrates, opening the way for the design of therapeutic approaches based on the inhibition or even the exploitation of transporters in cancer cells.

Original languageEnglish
JournalArchives of Toxicology
DOIs
Publication statusPublished - Jan 1 2019

Fingerprint

Cytotoxicity
Fluorescence
Assays
Substrates
Pharmaceutical Preparations
Toxicity
Coculture Techniques
Cells
Drug interactions
Neoplasms
Chemotherapy
Membrane Transport Proteins
Multiple Drug Resistance
P-Glycoprotein
Drug-Related Side Effects and Adverse Reactions
Drug Interactions
Metabolism
Antineoplastic Agents
In Vitro Techniques
Screening

Keywords

  • Anticancer drugs
  • ATP-binding cassette transporters
  • Cytotoxicity
  • High-throughput screen
  • Organic Anon Transporting Polypeptides

ASJC Scopus subject areas

  • Toxicology
  • Health, Toxicology and Mutagenesis

Cite this

Identification of anticancer OATP2B1 substrates by an in vitro triple-fluorescence-based cytotoxicity screen. / Windt, Tímea; Tóth, Szilárd; Patik, Izabel; Sessler, Judit; Kucsma, Nóra; Szepesi, Áron; Zdrazil, Barbara; Özvegy-Laczka, C.; Szakács, G.

In: Archives of Toxicology, 01.01.2019.

Research output: Contribution to journalArticle

Windt, Tímea ; Tóth, Szilárd ; Patik, Izabel ; Sessler, Judit ; Kucsma, Nóra ; Szepesi, Áron ; Zdrazil, Barbara ; Özvegy-Laczka, C. ; Szakács, G. / Identification of anticancer OATP2B1 substrates by an in vitro triple-fluorescence-based cytotoxicity screen. In: Archives of Toxicology. 2019.
@article{40ee8dd1e8fd4b0cb222a3b75fdffa2e,
title = "Identification of anticancer OATP2B1 substrates by an in vitro triple-fluorescence-based cytotoxicity screen",
abstract = "Membrane transporters play an important role in the absorption, distribution, metabolism and excretion of drugs. The cellular accumulation of many drugs is the result of the net function of efflux and influx transporters. Efflux transporters such as P-glycoprotein/ABCB1 have been shown to confer multidrug resistance in cancer. Although expression of uptake transporters has been confirmed in cancer cells, their role in chemotherapy response has not been systematically investigated. In the present study we have adapted a fluorescence-based cytotoxic assay to characterize the influence of key drug-transporters on the toxicity of approved anticancer drugs. Co-cultures of fluorescently labeled parental and transporter-expressing cells (expressing ABCB1, ABCG2 or OATP2B1) were screened against 101 FDA-approved anticancer drugs, using a novel, automated, triple fluorescence-based cytotoxicity assay. By measuring the survival of parental and transporter-expressing cells in co-cultures, we identify those FDA-approved anticancer drugs, whose toxicity is influenced by ABCB1, ABCG2 or OATP2B1. In addition to confirming known substrates of ABCB1 and ABCG2, the fluorescence-based cytotoxicity assays identified anticancer agents whose toxicity was increased in OATP2B1 expressing cells. Interaction of these compounds with OATP2B1 was verified in dedicated transport assays using cell-impermeant fluorescent substrates. Understanding drug-transporter interactions is needed to increase the efficacy of chemotherapeutic agents. Our results highlight the potential of the fluorescence-based HT screening system for identifying transporter substrates, opening the way for the design of therapeutic approaches based on the inhibition or even the exploitation of transporters in cancer cells.",
keywords = "Anticancer drugs, ATP-binding cassette transporters, Cytotoxicity, High-throughput screen, Organic Anon Transporting Polypeptides",
author = "T{\'i}mea Windt and Szil{\'a}rd T{\'o}th and Izabel Patik and Judit Sessler and N{\'o}ra Kucsma and {\'A}ron Szepesi and Barbara Zdrazil and C. {\"O}zvegy-Laczka and G. Szak{\'a}cs",
year = "2019",
month = "1",
day = "1",
doi = "10.1007/s00204-019-02417-6",
language = "English",
journal = "Archiv fur Toxikologie",
issn = "0003-9446",
publisher = "Springer Verlag",

}

TY - JOUR

T1 - Identification of anticancer OATP2B1 substrates by an in vitro triple-fluorescence-based cytotoxicity screen

AU - Windt, Tímea

AU - Tóth, Szilárd

AU - Patik, Izabel

AU - Sessler, Judit

AU - Kucsma, Nóra

AU - Szepesi, Áron

AU - Zdrazil, Barbara

AU - Özvegy-Laczka, C.

AU - Szakács, G.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Membrane transporters play an important role in the absorption, distribution, metabolism and excretion of drugs. The cellular accumulation of many drugs is the result of the net function of efflux and influx transporters. Efflux transporters such as P-glycoprotein/ABCB1 have been shown to confer multidrug resistance in cancer. Although expression of uptake transporters has been confirmed in cancer cells, their role in chemotherapy response has not been systematically investigated. In the present study we have adapted a fluorescence-based cytotoxic assay to characterize the influence of key drug-transporters on the toxicity of approved anticancer drugs. Co-cultures of fluorescently labeled parental and transporter-expressing cells (expressing ABCB1, ABCG2 or OATP2B1) were screened against 101 FDA-approved anticancer drugs, using a novel, automated, triple fluorescence-based cytotoxicity assay. By measuring the survival of parental and transporter-expressing cells in co-cultures, we identify those FDA-approved anticancer drugs, whose toxicity is influenced by ABCB1, ABCG2 or OATP2B1. In addition to confirming known substrates of ABCB1 and ABCG2, the fluorescence-based cytotoxicity assays identified anticancer agents whose toxicity was increased in OATP2B1 expressing cells. Interaction of these compounds with OATP2B1 was verified in dedicated transport assays using cell-impermeant fluorescent substrates. Understanding drug-transporter interactions is needed to increase the efficacy of chemotherapeutic agents. Our results highlight the potential of the fluorescence-based HT screening system for identifying transporter substrates, opening the way for the design of therapeutic approaches based on the inhibition or even the exploitation of transporters in cancer cells.

AB - Membrane transporters play an important role in the absorption, distribution, metabolism and excretion of drugs. The cellular accumulation of many drugs is the result of the net function of efflux and influx transporters. Efflux transporters such as P-glycoprotein/ABCB1 have been shown to confer multidrug resistance in cancer. Although expression of uptake transporters has been confirmed in cancer cells, their role in chemotherapy response has not been systematically investigated. In the present study we have adapted a fluorescence-based cytotoxic assay to characterize the influence of key drug-transporters on the toxicity of approved anticancer drugs. Co-cultures of fluorescently labeled parental and transporter-expressing cells (expressing ABCB1, ABCG2 or OATP2B1) were screened against 101 FDA-approved anticancer drugs, using a novel, automated, triple fluorescence-based cytotoxicity assay. By measuring the survival of parental and transporter-expressing cells in co-cultures, we identify those FDA-approved anticancer drugs, whose toxicity is influenced by ABCB1, ABCG2 or OATP2B1. In addition to confirming known substrates of ABCB1 and ABCG2, the fluorescence-based cytotoxicity assays identified anticancer agents whose toxicity was increased in OATP2B1 expressing cells. Interaction of these compounds with OATP2B1 was verified in dedicated transport assays using cell-impermeant fluorescent substrates. Understanding drug-transporter interactions is needed to increase the efficacy of chemotherapeutic agents. Our results highlight the potential of the fluorescence-based HT screening system for identifying transporter substrates, opening the way for the design of therapeutic approaches based on the inhibition or even the exploitation of transporters in cancer cells.

KW - Anticancer drugs

KW - ATP-binding cassette transporters

KW - Cytotoxicity

KW - High-throughput screen

KW - Organic Anon Transporting Polypeptides

UR - http://www.scopus.com/inward/record.url?scp=85063012474&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85063012474&partnerID=8YFLogxK

U2 - 10.1007/s00204-019-02417-6

DO - 10.1007/s00204-019-02417-6

M3 - Article

AN - SCOPUS:85063012474

JO - Archiv fur Toxikologie

JF - Archiv fur Toxikologie

SN - 0003-9446

ER -